Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/1756-185X.70297 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Network pharmacology prediction and experimental validation to explore the potential mechanism of Danggui Shaoyao San against Acute Kidney Injury.
J Ethnopharmacol
September 2025
Department of Traditional Chinese Medicine, Qingdao Municipal Hospital, Qingdao, China. Electronic address:
Ethnopharmacological Relevance: Acute kidney injury (AKI) is a growing worldwide health concern. Danggui Shaoyao San (DGSYS) was an frequently-used representative prescription to "promote blood and water and harmonize the body" in traditional Chinese medicine, and its underlying mechanism against AKI remains to be elucidated.
Aim Of The Study: To investigate the protective effect and potential molecular mechanism of DGSYS in alleviating AKI by network pharmacology and experiment validation.
Pharmacologically active constituents of Buyang Huanwu Decoction against cerebral ischemia-reperfusion injury and verification of its effects on oxidative stress, energy metabolism, and inflammation.
J Ethnopharmacol
August 2025
Hunan University of Chinese Medicine, Changsha, 410208, China; School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China. Electronic address:
Ethnopharmacological Relevance: Buyang Huanwu Decoction (BYHWD) is traditionally prescribed for Qi-deficiency and blood-stasis stroke in TCM, yet its key pharmacologically active constituents and mechanistic basis remain to be fully elucidated.
Aim Of The Study: To investigate the key pharmacologically active constituents of BYHWD against Qi-deficiency and blood-stasis type cerebral ischemia-reperfusion injury (QDBS + CI/R), and to clarify their roles in counteracting oxidative stress, suppressing inflammation, and improving energy metabolism.
Methods: A QDBS + CI/R rat model was used to assess BYHWD's therapeutic effects via neurological and syndrome scoring, histology (HE, Nissl), and biochemical markers (T-AOC, IL-1β, IL-6, ATP, ADP).
Paeoniflorin improves atherosclerosis by regulating the gut microbiota and fecal metabolites.
mSystems
August 2025
Precision and Transformation Laboratory of Traditional Chinese Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, China.
Atherosclerosis (AS) is a chronic inflammatory disease and a key factor in cardiovascular disease. Paeoniflorin (PF), a monomer component extracted from red and white paeony roots, has been used for the prevention and treatment of cardiovascular diseases, but the specific mechanism remains unclear. ApoE mice fed a high-fat diet were randomly divided into a model group, a PF treatment group, a positive control group, and a control group fed a non-high-fat diet.
View Article and Find Full Text PDFPaeoniflorin attenuates neuropathic Pain-associated depression by modulating microglial M1 polarization and correcting kynurenine pathway dysregulation.
Int Immunopharmacol
August 2025
Hebei Key Laboratory of Research and Development for Chinese Medicine, Chengde Medical University, Hebei, Chengde 067000, China. Electronic address:
Neuropathic pain (NP) is increasingly recognized as a chronic stressor contributing to the development of depressive comorbidities through neuroimmune dysregulation. However, the mechanistic interplay between microglial polarization states and kynurenine pathway (KP) metabolism in this process remains incompletely understood. The present study investigated the therapeutic potential of paeoniflorin (PF), a bioactive monoterpene glycoside, in alleviating NP-associated depression by modulating the M1 microglial M1 polarization-kynurenine 3-monooxygenase (KMO) pathway.
View Article and Find Full Text PDF